EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Brefeldin A and M-COPA block the export of RTKs from the endoplasmic reticulum via simultaneous inactivation of ARF1, ARF4, and ARF5

Miyuki Natsume, Mariko Niwa, Sho Ichikawa, Takuma Okamoto, Hisazumi Tsutsui, Daiki Usukura, Takatsugu Murata, Ryo Abe, Motoyuki Shimonaka, Toshirou Nishida, Isamu Shiina, Yuuki Obata

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Miyuki Natsume und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Intracellular Traffic & Oncology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan; Faculty of Science, Department of A…. Hauptthemen laut MEDLINE: ADP-Ribosylation Factors, Endoplasmic Reticulum, ADP-Ribosylation Factor 1, Brefeldin A. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Foundation for Applied Enzymology, Suzuken Memorial Foundation, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Normal receptor tyrosine kinases (RTKs) need to reach the plasma membrane (PM) for ligand-induced activation, whereas its cancer-causing mutants can be activated before reaching the PM in organelles, such as the Golgi/trans-Golgi network (TGN). Inhibitors of protein export from the endoplasmic reticulum (ER), such as brefeldin A (BFA) and 2-methylcoprophilinamide (M-COPA), can suppress the activation of mutant RTKs in cancer cells, suggesting that RTK mutants cannot initiate signaling in the ER. BFA and M-COPA block the function of ADP-ribosylation factors (ARFs) that play a crucial role in ER-Golgi protein trafficking. However, among ARF family proteins, the specific ARFs inhibited by BFA or M-COPA, that is, the ARFs involved in RTKs transport from the ER, remain unclear. In this study, we showed that M-COPA blocked the export of not only KIT but also PDGFRA/EGFR/MET RTKs from the ER. ER-retained RTKs could not fully transduce anti-apoptotic signals, thereby leading to cancer cell apoptosis. Moreover, a single knockdown of ARF1, ARF3, ARF4, ARF5, or ARF6 could not block ER export of RTKs, indicating that BFA/M-COPA treatment cannot be mimicked by the knockdown of only one ARF member. Interestingly, simultaneous transfection of ARF1, ARF4, and ARF5 siRNAs mirrored the effect of BFA/M-COPA treatment. Consistent with these results, in vitro pulldown assays showed that BFA/M-COPA blocked the function of ARF1, ARF4, and ARF5. Taken together, these results suggest that BFA/M-COPA targets at least ARF1, ARF4, and ARF5; in other words, RTKs require the simultaneous activation of ARF1, ARF4, and ARF5 for their ER export.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADP-Ribosylation FactorsEndoplasmic ReticulumADP-Ribosylation Factor 1Brefeldin AProtein TransportHumansErbB ReceptorsHeLa Cells

Stichwörter der Autor:innen

ARFBFAEGFRGEFGolgi/TGNKITM-COPAMETRTKendoplasmic reticulum

Substanzen

ADP-Ribosylation FactorsADP-Ribosylation Factor 1Brefeldin AARF4 protein, humanARF1 protein, humanARF5 protein, humanErbB Receptors

Autor:innen und Institutionen

  • Laboratory of Intracellular Traffic & Oncology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan; Faculty of Science, Department of Applied Chemistry, Tokyo University of Science, Shinjuku-ku, Tokyo, Jap…
  • Laboratory of Intracellular Traffic & Oncology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan; Faculty of Science, Department of Chemistry, Tokyo University of Science, Shinjuku-ku, Tokyo, Japan.
  • Faculty of Science, Department of Applied Chemistry, Tokyo University of Science, Shinjuku-ku, Tokyo, Japan.
  • Tokyo University of Science, Noda, Chiba, Japan.
  • Faculty of Science, Department of Chemistry, Tokyo University of Science, Shinjuku-ku, Tokyo, Japan.
  • National Cancer Center Hospital, Chuo-ku, Tokyo, Japan; Laboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan.

Förderung

  • Japan Foundation for Applied Enzymology
  • Suzuken Memorial Foundation
  • Japan Society for the Promotion of Science

Zitieren

APA

Natsume, M., Niwa, M., Ichikawa, S., Okamoto, T., Tsutsui, H., Usukura, D., Murata, T., Abe, R., Shimonaka, M., Nishida, T., Shiina, I., & Obata, Y. (2024). Brefeldin A and M-COPA block the export of RTKs from the endoplasmic reticulum via simultaneous inactivation of ARF1, ARF4, and ARF5. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107327

Vancouver

Natsume M, Niwa M, Ichikawa S, Okamoto T, Tsutsui H, Usukura D, et al. Brefeldin A and M-COPA block the export of RTKs from the endoplasmic reticulum via simultaneous inactivation of ARF1, ARF4, and ARF5. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107327

BibTeX
@article{Natsume2024,
  author = {Natsume, Miyuki and Niwa, Mariko and Ichikawa, Sho and Okamoto, Takuma and Tsutsui, Hisazumi and Usukura, Daiki and Murata, Takatsugu and Abe, Ryo and Shimonaka, Motoyuki and Nishida, Toshirou and Shiina, Isamu and Obata, Yuuki},
  title = {Brefeldin A and M-COPA block the export of RTKs from the endoplasmic reticulum via simultaneous inactivation of ARF1, ARF4, and ARF5},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107327}
}
Kostenlos starten →